Kevin Chiu
Overview
Explore the profile of Kevin Chiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
190
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hague T, Lad R, Chiu K
BJR Case Rep
. 2024 Jul;
10(4):uaae020.
PMID: 38983110
Reirradiation in recurrent head and neck cancer presents a considerable clinical challenge in radiation oncology. Though technically feasible due to advanced treatment delivery and planning techniques, confidence in delivering such...
2.
Tsolaki E, Kashanian A, Chiu K, Bari A, Pouratian N
Neuroimage Clin
. 2024 Feb;
41:103587.
PMID: 38422832
Objective: Deep brain stimulation (DBS) studies have shown that stimulation of the motor segment of the thalamus based on probabilistic tractography is predictive of improvement in essential tremor (ET). However,...
3.
MacEwan J, Chiu K, Ahmad N, Sacks N, Shinde S, Poon J, et al.
Obes Sci Pract
. 2024 Jan;
10(1):e726.
PMID: 38263999
Objectives: This study aimed to estimate clinical, economic (including productivity), and health-related quality of life (HRQoL) outcomes and associated individual characteristics among adults with overweight (OW) or obesity in the...
4.
Allam K, Wang X, Zhang S, Ding J, Chiu K, Saluja K, et al.
Ann Clin Lab Sci
. 2024 Jan;
53(6):819-824.
PMID: 38182154
Objective: Deep learning has been shown to be useful in detecting breast cancer metastases by analyzing whole slide images (WSI) of sentinel lymph nodes; however, it requires extensive analysis of...
5.
Grivas P, Veeranki P, Chiu K, Pawar V, Chang J, Bharmal M
Future Oncol
. 2023 Mar;
19(5):369-383.
PMID: 36876486
Investigate oncologist and patient preferences for the first-line treatment of advanced urothelial carcinoma. A discrete-choice experiment was used to elicit treatment attribute preferences, including patient treatment experience (number and duration...
6.
Bhatia S, Nghiem P, Veeranki S, Vanegas A, Lachance K, Tachiki L, et al.
J Immunother Cancer
. 2022 Aug;
10(8).
PMID: 35981787
Background: Merkel cell carcinoma (MCC) is a rare, aggressive, cutaneous neuroendocrine neoplasm with annual incidence rates of 0.13-1.6 cases/100,000/year worldwide as of 2018. Chemotherapy for metastatic MCC (mMCC) has high...
7.
Chiu K, MacEwan J, May S, Bognar K, Peneva D, Zhao L, et al.
MDM Policy Pract
. 2022 Aug;
7(2):23814683221113846.
PMID: 35936828
Highlights: Cancer can have a profound impact on productivity. This study demonstrates how the disease affects not only patients but also the informal or unpaid individuals who care for patients.An...
8.
Birch K, Snider J, Chiu K, Baumgardner J, Wade S, Shah G
Future Oncol
. 2022 Jul;
18(25):2791-2804.
PMID: 35837970
We quantified patient preferences for second-line diffuse large B-cell lymphoma therapies, including attributes of chimeric antigen receptor (CAR) T-cell therapy. Using a discrete choice experiment, we surveyed 224 diffuse large...
9.
Malekmohammadi M, Mustakos R, Sheth S, Pouratian N, McIntyre C, Bijanki K, et al.
J Neural Eng
. 2022 Jul;
19(4).
PMID: 35790135
Therapeutic efficacy of deep brain stimulation (DBS) in both established and emerging indications, is highly dependent on accurate lead placement and optimized clinical programming. The latter relies on clinicians' experience...
10.
Forma F, Chiu K, Shafrin J, Boskovic D, Veeranki S
Digit Health
. 2022 Mar;
8:20552076221084472.
PMID: 35295765
Background: Adherence to antipsychotic medication is critical for bipolar disorder (BPD), major depression (MDD) and schizophrenia (SCZ) patients. Digital tools have emerged to monitor medication adherence along with tracking general...